Zdrowie i gospodarka · 06/08/2010
FDA Releases Draft Guidance for Industry and FDA Staff on Premarket Notifications for Lamotrigine and Zonisamide Assays
The FDA has made available a draft guidance document outlining the necessary information for premarket notifications related to lamotrigine and zonisamide assays, which is currently not final or in effect.
Source: Federal Register — Health and Human ServicesOpen original release →